Evidence map›Paper›PMID 19516110›Full record

ArticleAIDS (London, England)2009

HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response.

Anne Piantadosi, Bhavna Chohan, Dana Panteleeff, Jared M Baeten, Kishorchandra Mandaliya, Jeckoniah O Ndinya-Achola, Julie Overbaugh

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Antiretroviral Drug-Resistance Mutations on thePathogens (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Anne PiantadosiDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.
Bhavna Chohan
Dana Panteleeff
Jared M Baeten
Kishorchandra Mandaliya
Jeckoniah O Ndinya-Achola
Julie Overbaugh
Fred Hutch Cancer Center · USUniversity of Nairobi · KEUniversity of Washington · US

Funding

University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1R37AI038518 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 1999 to 2019
$12.9M
NIAID NIH HHS R37 AI038518NIAID NIH HHS T32 AI007140NIGMS NIH HHS T32 GM007266NIGMS NIH HHS T32 GM07266
6 · The paper itself

Abstract

objectiveTo evaluate relationships between HIV-1 evolution, including immune evasion, and markers of disease progression during chronic infection.

designHIV-1 evolution and disease progression markers were evaluated over approximately 5 years of infection among 37 Kenyan women from a prospective, seroincident cohort. Evolution was measured in two genes, gag and env, which are primary targets of cellular and humoral immune responses, respectively.

methodsProviral HIV-1 gag and env sequences were obtained from early and chronic infection when plasma viral load and CD4 cell counts were available. Human leukocyte antigen types were obtained to identify changes in gag cytotoxic T-lymphocyte epitopes. The breadth of the neutralizing antibody response was measured for each woman's plasma against a panel of six viruses. Tests of association were performed between virus evolution (diversity, divergence, and ratio of nonsynonymous to synonymous divergence), markers of disease progression (viral load and CD4 cell count), and immune parameters (gag cytotoxic T lymphocyte epitope mutation and neutralizing antibody breadth).

resultsHIV-1 gag and env diversity and divergence were highly correlated in early and late infection. Divergence in gag was strongly correlated with viral load, largely because of the accumulation of synonymous changes. Mutation in gag cytotoxic T-lymphocyte epitopes was associated with higher viral load. There was evidence for adaptive evolution in env, but the extent of env evolution was only weakly associated with neutralizing antibody breadth.

conclusionOur results indicate that HIV-1 evolution in gag and env is highly correlated but exhibits gene-specific differences. The different immune pressures on these genes may partly explain differences in evolution and consequences for HIV-1 disease progression.

Indexed as

Antibodies, ViralCD4 Lymphocyte CountChronic DiseaseDisease Progressionenv Gene Products, Human Immunodeficiency VirusEpidemiologic MethodsEpitopes, T-LymphocyteEvolution, MolecularFemalegag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHumansMutationT-Lymphocytes, CytotoxicT-Lymphocyte SubsetsAntibodies, Viralenv Gene Products, Human Immunodeficiency VirusEpitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency Virus

Identifiers

PMID19516110
PMCPMC2727980
OpenAlexW1986371227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.